Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06956781 · ClinicalTrials.gov registry record · NA

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

A NA study of PTSD and Trauma, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06956781 is a NA study of PTSD and Trauma that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 200 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06956781, a NA study of PTSD and Trauma, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components used to treat PTSD? What do these components change to produce benefits in PTSD? Researchers will: Compare components to a psychological placebo to estimate their effects and measure how they work Examine how components work alone and in conjunction with other components Participants will: Receive different combinations of components and placebo Attend weekly treatment sessions Provide information to evaluate changes in PTSD

Interventions

  • BEHAVIORAL Emotion Regulation
  • BEHAVIORAL Exposure
  • BEHAVIORAL Cognitive Processing
  • BEHAVIORAL Bi-lateral Stimulation
  • BEHAVIORAL Psychological Placebo

Study Locations (1)

New York

  • The Mt. Hope Family Center - Rochester

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2026-01
Est. Completion 2028-08
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT06956781

The ClinicalTrials.gov registry entry for NCT06956781 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (34% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 5 interventions - of which Emotion Regulation is the first listed.

NCT06956781 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06956781 about?

NCT06956781 is a clinical study titled "Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)". The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components u...

What is the current status of trial NCT06956781?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-01. Estimated completion is 2028-08.

What conditions does trial NCT06956781 study?

This clinical trial studies the following conditions: PTSD, Trauma, Pediatric ALL.

What interventions are being tested in trial NCT06956781?

The interventions under investigation include: Emotion Regulation (BEHAVIORAL), Exposure (BEHAVIORAL), Cognitive Processing (BEHAVIORAL), Bi-lateral Stimulation (BEHAVIORAL), Psychological Placebo (BEHAVIORAL).

Who is sponsoring clinical trial NCT06956781?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06956781 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.